Hair restoration study begun in men with androgenetic alopecia

Theradome announced in a press release it has begun recruiting men with androgenetic alopecia in a 26-week clinical trial of its over-the-counter wearable hair restoration device that uses targeted laser energy.

The Theradome LH80 PRO Laser Helmet is FDA-cleared for women, according to the release. Ken Washenik, MD, PhD, a clinical researcher in hair loss, will oversee the study, according to the release.

Northwest Dermatology in Portland, Ore, MedaPhase LLC in Atlanta and Tennessee Clinical Research Center in Nashville are recruiting men aged 18 to 50 years who have thinning hair or are showing signs of balding, the release stated. The double-blind, randomized study will compare the Theradome LH80 PRO with a sham device worn by a control group to determine the product’s hair growth ability.

The device, developed by Tamim Hamid, MS, PhD, a former NASA scientist, uses laser phototherapy, or low-level laser light therapy, to stimulate weak hair follicles through targeted laser energy, according to the release. The device can be worn twice a week for 20 minutes, with most participants reporting results in 18 weeks, the release stated.

"We are now diligently working to bring men those same benefits as seen by women using the device around the globe,” Hamid said in the release.

Reference: www.theradome.com